Last updated: June 2026 · Reviewed June 2026 · Built by the InjectBuddy team
Where should you inject peptides? sites, rotation and BPC-157
Most peptides — including GLP-1 medications like semaglutide and tirzepatide, plus recovery peptides like BPC-157 — are injected subcutaneously into the fatty layer of the abdomen, outer thigh, or back of the upper arm. The default site is the abdomen, staying at least 2 inches from the navel, with sites rotated every dose. This guide covers where to inject peptides, the belly-button spacing rule, GLP-1 rotation, and the local-vs-systemic question for BPC-157 by injury.
Key takeaways
- Default peptide site is SubQ abdomen; alternatives are outer thigh and back of upper arm.
- Stay at least 2 inches (5 cm) from the belly button — that tissue is dense, sensitive, and absorbs unreliably.
- Rotate every injection, at least 2 cm apart, to avoid lumps and keep absorption steady.
- BPC-157 can be injected near a localised injury or systemically in the abdomen — the choice depends on the target.
- Work your reconstituted dose out first in the peptide reconstitution calculator or BPC-157 calculator.
Where do you inject peptides?
For most at-home peptide users the default site is subcutaneous fat in the abdomen, with the outer thigh and the back of the upper arm as the main alternatives. Peptides go into the fat layer just beneath the skin — the same technique as insulin and GLP-1 pens — not into muscle. The abdomen is most recommended because it has a reliable fat layer, is easy to see and reach, and gives consistent absorption.
| Site | Ease of self-injection | Notes |
|---|---|---|
| Abdomen | Easy | Default site; stay 2 in / 5 cm from the navel |
| Outer thigh | Easy | Good second region for rotation |
| Back of upper arm | Harder | May need assistance to reach |
| Near an injury (BPC-157) | Varies | Only for localised recovery peptides — see BPC section |
How far from the belly button do you inject?
Stay at least 2 inches (about 5 cm) away from the navel in every direction. The tissue immediately around the belly button is dense and fibrous, so injecting too close causes more pain, more bruising, and less consistent absorption. Treat the 2-inch rule as a hard boundary, not a suggestion — and avoid any scars or bruised skin within the zone. You can inject above or below the navel as long as you keep that 2-inch clearance and follow your product's instructions.
GLP-1 injection site rotation (semaglutide & tirzepatide)
For GLP-1 medications, divide the abdomen into four quadrants and rotate clockwise, using a different specific spot within each quadrant on consecutive injections. The recommended regions are the abdomen, thigh, and upper arm, rotated with each weekly dose to prevent pain, bruising, and skin thickening. Because most GLP-1s are once-weekly, even a simple quadrant cycle gives each spot weeks to recover. Work out your dose in units first with the semaglutide calculator or tirzepatide calculator.
Peptide rotation chart & schedule
Treat each region as a grid of spots spaced ~2–3 cm apart and cycle through them in order before any spot repeats. For a once-weekly GLP-1, rotating four abdominal quadrants plus the thighs means a single spot may not be reused for months. For daily peptides, add more regions so each spot still gets days to heal.
BPC-157 injection sites: local vs systemic
The most common BPC-157 question isn't how to rotate — it's whether to inject near the injury or systemically in the abdomen. The practical rule users and protocols follow: if you can pinch skin within about 3 cm of the injured structure, inject locally; if the injury is too deep to reach (hip socket, spinal disc) or the goal is gut/systemic support, inject subcutaneously in the abdomen. Local injection is thought to create a higher concentration at the tissue before the peptide enters circulation; systemic injection relies on BPC-157's reported tissue-homing to reach the target.
For a diffuse area like the knee, rotate across at least three sites around the joint, keeping injections at least 2 cm apart, rather than hitting one spot repeatedly.
| Target | Where to inject | Local or systemic |
|---|---|---|
| Knee | Around the joint, ~2–3 cm from the kneecap edge; rotate ≥3 sites | Local |
| Shoulder / rotator cuff | Anterior or lateral deltoid fat pad | Local |
| Achilles | Lateral to the tendon, ~1–2 cm above the heel | Local |
| Elbow | Subcutaneous tissue adjacent to the joint | Local |
| Gut / IBS / ulcers | Abdomen (or oral) | Systemic |
| Deep / unreachable injury | Abdomen | Systemic |
Evidence caveat: BPC-157 is not FDA-approved, and most support comes from preclinical (animal) studies plus user protocols, not large human trials. The FDA has flagged concerns about compounded BPC-157. This section describes what protocols report, not established clinical guidance — confirm any use with a qualified clinician.
Reconstitute and dose with the BPC-157 calculator; for blends see BPC+TB500 calculator.
Signs of poor rotation
The signs you're overusing a peptide injection site are firm or rubbery lumps, persistent soreness, bruising, and slowing or erratic absorption. Repeated injections into the same spot cause tissue damage and lipohypertrophy, which then absorbs the peptide unevenly. Rotating sites gives the skin time to heal and keeps delivery consistent — apply a cold compress after injecting if a site is tender.
So, where should you inject peptides?
For most at-home protocols the answer is the subcutaneous fat of the abdomen, staying at least 2 inches (5 cm) from the navel and rotating each injection at least 2 cm from the last. The outer thigh and back of the upper arm are reliable second and third regions. BPC-157 can be injected locally near a reachable injury or systemically in the abdomen for deeper or gut targets. Work out your exact dose and draw volume before every injection with the peptide reconstitution calculator.
Frequently asked questions
Where should you inject peptides?
Where is the best place to inject peptides?
How far from the belly button should I inject?
How do I rotate GLP-1 injection sites?
Should I inject BPC-157 near the injury or in my stomach?
Where do I inject BPC-157 for knee pain?
Can peptides go into muscle?
Sources
- Frid AH, Kreugel G, Grassi G, et al. New Insulin Delivery Recommendations. Mayo Clinic Proceedings. 2016;91(9):1231–55 — subcutaneous site rotation guidance for insulin and GLP-1 pens. PubMed.
- Blanco M, Hernández MT, Strauss KW, Amaya M. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes & Metabolism. 2013;39(5):445–53 — non-rotation is the strongest predictor of lipohypertrophy. PubMed.
- Vasireddi N, Hahamyan H, et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS Journal. 2025 — evidence base is largely preclinical; BPC-157 is not FDA-approved. PubMed.
- Chang CH, Tsai WC, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology. 2011;110(3):774–80 — preclinical (animal) mechanism study. PubMed.
- CDC. Safe Injection Practices to Prevent Transmission of Infections to Patients. 2024. CDC clinical guidance.
This guide is for general educational purposes only and does not constitute medical advice. InjectBuddy is a maths and reference tool, not a medical service. Always follow your prescriber's specific instructions on where, how, and how often to inject.